Last week researchers from the United States and London’s Royal Veterinary College published a paper demonstrating that gene editing techniques …
Gene editing restores dystrophin production in dog model of DuchenneRead More

6 September 2018 by abzali123
Last week researchers from the United States and London’s Royal Veterinary College published a paper demonstrating that gene editing techniques …
Gene editing restores dystrophin production in dog model of DuchenneRead More

30 August 2018 by abzali123
We’ve just heard that Pfizer is halting clinical trials of domagrozumab for Duchenne muscular dystrophy after it failed to show effectiveness in …
Pfizer to discontinue trials of domagruzumab in DuchenneRead More

30 August 2018 by abzali123
Tomorrow, 7th September, marks annual Duchenne Awareness Day – a day in which the entire community comes together with one clear mission – …

16 August 2018 by abzali123
Wave Life Sciences has announced that the Drug Regulator in the USA – the FDA - has granted both orphan drug designation and rare paediatric …

14 August 2018 by abzali123
Please take a few minutes to complete this short, anonymous online survey to find out about the side effects of steroids that impacts most on quality …

31 July 2018 by abzali123
Last week PTC Therapeutics published a paper demonstrating that over 1 year, deflazacort slowed the decline in the distance boys living with Duchenne …
PTC use ataluren trial data to investigate steroidsRead More

26 July 2018 by abzali123
Yesterday, Sarepta Therapeutics announced that the FDA has issued a Clinical Hold letter for the company’s phase I/II trial testing the safety and …

23 July 2018 by abzali123
We have been offered a number of paid internships for young people living with Duchenne. The positions are available this summer across a range of …

19 July 2018 by abzali123
Last week our Director of Campaigns & Strategy, Peter Duffy, attended a meeting at The Medicines and Healthcare products Regulatory …

10 July 2018 by abzali123
Catabasis has announced plans to start a global phase 3 trial to test the safety and effectiveness of a potential drug called edasalonexent in people …
Catabasis announces plans for global trial of edasalonexentRead More

10 July 2018 by abzali123
A huge THANK YOU to the 12 amazing fundraisers who jumped out of planes across the country for Duchenne muscular dystrophy this weekend! YouTube …

5 July 2018 by abzali123
A huge thank you and well done to the incredible Alexis Ellison who completed his 24 hour mammoth bike ride - cycling the 9 mile road back …
Action Duchenne
5th Floor, Mariner House
62 Prince Street
Bristol
BS1 4QD
07535 498 506
info@actionduchenne.org
